HRPK20041201B3 - Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof - Google Patents

Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof

Info

Publication number
HRPK20041201B3
HRPK20041201B3 HR20041201A HRP20041201A HRPK20041201B3 HR PK20041201 B3 HRPK20041201 B3 HR PK20041201B3 HR 20041201 A HR20041201 A HR 20041201A HR P20041201 A HRP20041201 A HR P20041201A HR PK20041201 B3 HRPK20041201 B3 HR PK20041201B3
Authority
HR
Croatia
Prior art keywords
alkyl
phenyl
cooh
alkylene
compounds
Prior art date
Application number
HR20041201A
Other languages
English (en)
Croatian (hr)
Inventor
Jaehne Gerhard
Frick Wendelin
Flohr Stefanie
Lindenschmidt Andreas
Glombik Heiner
Kramer Werner
Heuer Hubert
Schaefer Hans-Ludwig
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20041201A2 publication Critical patent/HRP20041201A2/xx
Publication of HRPK20041201B3 publication Critical patent/HRPK20041201B3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20041201A 2002-06-19 2003-06-04 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof HRPK20041201B3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10227508A DE10227508A1 (de) 2002-06-19 2002-06-19 Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
PCT/EP2003/005816 WO2004000805A1 (de) 2002-06-19 2003-06-04 Säuregruppen-substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Publications (2)

Publication Number Publication Date
HRP20041201A2 HRP20041201A2 (en) 2005-08-31
HRPK20041201B3 true HRPK20041201B3 (en) 2006-12-31

Family

ID=29719283

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20041201A HRPK20041201B3 (en) 2002-06-19 2003-06-04 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof

Country Status (28)

Country Link
EP (1) EP1517891B1 (enExample)
JP (1) JP2005533073A (enExample)
KR (1) KR20050008835A (enExample)
CN (1) CN100467448C (enExample)
AR (1) AR039690A1 (enExample)
AU (1) AU2003238210B2 (enExample)
BR (1) BR0311896A (enExample)
CA (1) CA2490112A1 (enExample)
DE (1) DE10227508A1 (enExample)
EC (1) ECSP045497A (enExample)
HN (1) HN2003000185A (enExample)
HR (1) HRPK20041201B3 (enExample)
IL (1) IL165789A0 (enExample)
MA (1) MA27206A1 (enExample)
MX (1) MXPA04012093A (enExample)
NO (1) NO20050134L (enExample)
OA (1) OA12869A (enExample)
PA (1) PA8576101A1 (enExample)
PE (1) PE20040564A1 (enExample)
PL (1) PL372700A1 (enExample)
RS (1) RS108404A (enExample)
RU (1) RU2287522C2 (enExample)
SV (1) SV2004001548A (enExample)
TN (1) TNSN04250A1 (enExample)
TW (1) TW200413311A (enExample)
UA (1) UA78577C2 (enExample)
UY (1) UY27853A1 (enExample)
WO (1) WO2004000805A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
WO2005061452A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
CN101115726A (zh) 2004-12-03 2008-01-30 先灵公司 作为cb1拮抗剂的取代哌嗪
WO2006107936A1 (en) * 2005-04-04 2006-10-12 Pontificia Universidad Catolica De Chile The use of ezetimibe in the prevention and treatment of cholesterol gallstones
ATE450526T1 (de) 2005-06-20 2009-12-15 Schering Corp Als antagonisten von histamin h3 geeignete piperidinderivate
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
MX2008016343A (es) * 2006-06-23 2009-01-19 Abbott Lab Derivados ciclopropil amina como moduladores del receptro de histamina h3.
BRPI0715160A2 (pt) 2006-08-08 2013-06-11 Sanofi Aventis imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
DE102007002260A1 (de) 2007-01-16 2008-07-31 Sanofi-Aventis Verwendung von substituierten Pyranonsäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CN101200443B (zh) * 2007-10-17 2011-06-29 中国药科大学 氮杂环丁酮衍生物、其制备方法及含有它们的药物组合
DE102007054497B3 (de) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
WO2010100255A1 (en) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
ES2443016T3 (es) 2009-08-26 2014-02-17 Sanofi Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3300B (en) * 1992-12-23 1995-06-26 Schering Corp Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
DE10042447A1 (de) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports
BR0116325A (pt) * 2000-12-21 2003-10-14 Aventis Pharma Gmbh 1,2-difenilazetidinonas, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação para o tratamento de distúrbios do metabolismo de lipìdios
ATE338039T1 (de) * 2000-12-21 2006-09-15 Sanofi Aventis Deutschland Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use

Also Published As

Publication number Publication date
NO20050134L (no) 2005-03-18
NO20050134D0 (no) 2005-01-11
ECSP045497A (es) 2005-03-10
TNSN04250A1 (en) 2007-03-12
TW200413311A (en) 2004-08-01
AU2003238210B2 (en) 2008-10-23
UA78577C2 (en) 2007-04-10
OA12869A (en) 2006-09-15
AR039690A1 (es) 2005-03-09
HN2003000185A (es) 2005-10-20
HK1079511A1 (zh) 2006-04-07
RU2005101093A (ru) 2005-07-20
RU2287522C2 (ru) 2006-11-20
IL165789A0 (en) 2006-01-15
DE10227508A1 (de) 2004-01-08
CN100467448C (zh) 2009-03-11
JP2005533073A (ja) 2005-11-04
KR20050008835A (ko) 2005-01-21
CA2490112A1 (en) 2003-12-31
BR0311896A (pt) 2005-04-05
PL372700A1 (en) 2005-07-25
RS108404A (sr) 2007-02-05
PE20040564A1 (es) 2004-10-25
HRP20041201A2 (en) 2005-08-31
MA27206A1 (fr) 2005-01-03
PA8576101A1 (es) 2004-02-07
WO2004000805A1 (de) 2003-12-31
MXPA04012093A (es) 2005-04-19
UY27853A1 (es) 2003-12-31
EP1517891B1 (de) 2013-04-03
AU2003238210A1 (en) 2004-01-06
CN1662495A (zh) 2005-08-31
SV2004001548A (es) 2004-03-19
EP1517891A1 (de) 2005-03-30

Similar Documents

Publication Publication Date Title
HRPK20041201B3 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
RU2498983C2 (ru) Соединения фениламинопиримидина и их применения
PL1996180T3 (pl) Pochodne benzamidu i pirydyloamidu jako czynniki antybakteryjne
MY140070A (en) 4-(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
TW200519092A (en) Malonamide derivatives
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
TR201904655T4 (tr) Piridilaminoasetik asit bileşiği.
AR033600A1 (es) Difenilazetidinona, medicamentos que contienen estos compuestos, procedimiento para su preparacion, y su utilizacion para preparar medicamentos
HRP20000854B1 (en) Therapeutic biaryl derivatives
NO20064400L (no) Prolin-derivater, og anvendelse av samme som inhibitorer av dipeptidyl peptidase IV
NO20070606L (no) Inhibitorer av IAP
TW200730514A (en) Morpholine type cinnamide compound
TW200635585A (en) Monocyclic substituted methanones
MY150781A (en) Phthalazine derivatives as parp inhibitors
HRP20080429T3 (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
NO20062517L (no) 2-cyanopyrrolidinkarboksamidforbindelse
PE20091400A1 (es) Derivados de n-(2-amino-fenil)-amida como inhibidores de hdac
JP2004516293A5 (enExample)
NO20064077L (no) Kemokinreseptorantagonister
ATE284860T1 (de) Neue verwendung von phenylheteroalkylamin- derivaten
BRPI0512615A (pt) compostos de sulfonamida
AR072904A1 (es) Compuestos de fenilamino-isonicotinamida y composiciones farmaceuticas que los contienen
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
MA32956B1 (fr) Derives de 5-amino-2-(1-hydroxyethyl)-tetrahydropyrane

Legal Events

Date Code Title Description
A1OB Publication of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

AKOB Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent)
PKB1 Consensual patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090602

Year of fee payment: 7

PBKO Lapse due to non-payment of renewal fee for consensual patent

Effective date: 20100605